3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
2
Advanced Malignancies
2
Urothelial Cancer
1
Thyroid Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
KRAS p.G12C Mutant Advanced Solid Tumors
1
Hematologic Neoplasms
1
Glioma
1
Gastrointestinal Stromal Tumors
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Specimen Handling
3
Doxorubicin
3
Biopsy
3
Radiotherapy
2
Radiation
2
Magnetic Resonance Spectroscopy
2
Gemcitabine
2
toripalimab
1
talimogene laherparepvec
1
ribociclib
1
peposertib
1
pazopanib
1
liposomal doxorubicin
1
cabozantinib
1
abemaciclib
1
Temozolomide
1
Surgical Procedures, Operative
1
PM 01183
1
Nivolumab
1
Neoadjuvant Therapy
1
Ifosfamide
1
Everolimus
1
Docetaxel
1
ADI PEG20
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leiomyosarcoma
×
Midazolam
×
90 days
×
Clear all
No trials found.